跳至主要内容
临床试验/NL-OMON51548
NL-OMON51548尚未招募4 期

Periarticular penetration of cefazolin and clindamycin in second stage revision arthroplasty of the hip. - CONCENTRATE

Radboud Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. Age 18 years or older.
  • 2. Scheduled second stage revision arthroplasty (reimplantation) of the hip
  • prosthesis preferably during clindamycin 600mg three times a day orally for
  • PJI, started at least 3 days before reimplantation.

排除标准

  • 1. Antibiotic prophylaxis other than cefazolin 2000mg i.v.
  • 2. Cefazolin use within 4 days previous to the reimplantation, other than the
  • single dose administration of surgical prophylaxis just before incision.
  • 3. Clindamycin loaded bone cement in situ.
  • 4. BMI more than 35 kg/m2.

研究者

相似试验